Warburg Pincus has closed its latest China companion fund – which officially includes Southeast Asia for this vintage – at the hard cap of $4.25 billion.
Australian GP Archer Capital has revived its plans to raise a sixth fund and set a target of A$300 million ($208 million), more than a year after halting the process amid the planned departure of Peter Wiggs, the firm’s founding partner and CEO.
After more than a decade with Warburg Pincus in China, David Li struck out on his own with Centurium Capital. Applying technology to traditional business models is central to his investment thesis
AVCJ's Japan Forum has been going for two decades, a period during which the industry has embarked on several roller-coaster journeys. For now, though, the market appears to be in good health
Negative perceptions and local sensitivities have stymied the development of secondary buyouts in Japan. International GPs – plus some of their domestic peers – have the firepower to drive change
China-based GPs Sinopharm Capital and Cedarlake Capital have announced a $20 million investment in Singapore-based healthcare platform Novena Global Lifecare, along with a strategic partnership for a $150 million fund that will support Southeast Asian...
As Japanese institutional investors seek to initiate or change up their private equity programs, GPs looking to build long-term relationships in the country must find the right way to engage
A Ripplewood Holdings-led consortium broke new ground for private equity with the turnaround of Long-Term Credit Bank of Japan. CEO Tim Collins explains why he boldly goes where others fear to tread
Japanese private equity firms are looking to raise larger funds, based on what is described as a blossoming investment opportunity. Do they risk biting off more than they can chew?
Fidelity International has announced plans to spin-out its proprietary investment arm Eight Roads within the year pending regulatory and shareholder approvals.
Nexus Point Capital has raised $475 million for middle-market buyouts in Greater China. The team, led by ex-MBK Partners executive K.C. Kung, favors complex solutions over plain vanilla deals
Recent appointments by two Asian GPs - Everstone Group and Legend Capital - offer insights into how smaller managers are trying to forge meaningful relationships with large institutional investors
Advent International has closed its latest global fund at the hard cap of $17.5 billion, completing its largest-ever fundraising exercise in the space of six months.
Joy Capital is seeking $350 million for its third China-focused venture capital fund, which would take the four-year-old firm’s assets under management past the $1 billion mark.
Patient, culture-oriented Chiratae Ventures has grown and diversified in step with India’s gradually blossoming VC market. Its latest expansions suggest this trajectory is set to accelerate
Pacific Equity Partners (PEP) has reached a first close of just over A$2 billion ($1.4 billion) on its sixth Australia and New Zealand-focused buyout fund, with the hard cap set at A$2.5 billion.
Asian private equity firms may start moving their fund management entities away from the Cayman Islands due to new economic substance requirements. Is Hong Kong ready to accept them?
A host of early movers in Southeast Asian venture debt are attempting to fill one of the last big gaps in the region’s start-up infrastructure. The outlook is promising, but adoption rates remain a concern
Malcolm Turnbull, whose three-year tenure as prime minister of Australia ended in August of last year, has joined KKR as a global senior advisor.
All China consumer deals are now technology deals, but investors must back up this positioning with meaningful value-add capabilities in areas such as digital marketing and data analytics or risk being accused of embellishing a technology thesis for the...
Warburg Pincus is targeting $4.25 billion for its second China companion fund, having officially added Southeast Asia to the mandate. The previous companion fund closed at $2 billion in late 2016 after three months in the market.
China’s start-up ecosystem is conforming to global norms by championing demanding work schedules, but companies must still consider ways to keep their employees suitably motivated
Food technology is a virtually endless horizon of profound and unignorable investment imperatives mistaken as a niche category. Alternative protein is the first opportunity set to gain serious traction
Sassoon Investment Corporation, the family office of the Sassoon family, and Indonesian bank CIMB Niaga have launched Genesis Alternative Ventures, a venture debt provider targeting start-ups in Southeast Asia.